Regenicin, Inc.【RGIN】
Market cap
$15.35K
P/E ratio
| Sep 30, 2011 | Sep 30, 2012 | Sep 30, 2013 | Sep 30, 2014 | Sep 30, 2015 | Sep 30, 2016 | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | |
| General and administrative | 3 | 4 | 5 | 698,339 | 1 | 1 | 970,824 | 789,105 | 705,729 | 663,749 | 842,364 |
| Total operating expenses | 4 | 7 | 11 | 725,895 | 241,823 | 1 | 976,108 | 789,105 | 736,553 | 663,749 | 842,364 |
| Interest expense related party of $(18,758), $(17,213) | - | - | - | - | - | - | - | - | - | 47,050 | -34,713 |
| Change in unrealized loss on securities | - | - | - | - | - | - | - | - | -3,950 | -1,725 | 25 |
| Total other expenses | -6,875 | -787,719 | -907,049 | 37,017 | 3 | -310,048 | -12,829 | 18,781 | 21,903 | 48,775 | 34,738 |
| Net loss | -3,665,582 | - | - | 2 | 242,599 | -1,089,902 | 973,937 | -559,058 | 758,456 | 559,591 | -877,102 |
| Preferred stock dividends | 1 | -108,134 | -46,198 | 70,800 | 70,800 | 70,994 | -70,800 | -70,800 | -70,800 | 70,992 | 70,405 |
| Net loss attributable to common stockholders | -3,665,582 | -3,146,658 | -4,904,812 | - | - | - | - | - | -829,256 | -630,583 | -947,507 |
| Loss per share basic | - | - | - | 0.02 | - | -0.01 | -0.01 | - | -0.01 | - | -0.01 |
| Loss per share diluted | - | - | - | 0.01 | - | -0.01 | -0.01 | - | -0.01 | - | -0.01 |